Cargando…

Clonal dissemination of Klebsiella pneumoniae resistant to cefiderocol, ceftazidime/avibactam, meropenem/vaborbactam and imipenem/relebactam co-producing KPC and OXA-181 carbapenemase

OBJECTIVES: Herein, we describe the epidemiology of carbapenemase-producing Enterobacterales (CPE) before and during the COVID-19 pandemic. Also, we report the emergence of an outbreak of Klebsiella pneumoniae strains co-producing KPC and OXA-181 carbapenemase, resistant to novel β-lactam/β-lactamas...

Descripción completa

Detalles Bibliográficos
Autores principales: Bovo, Federica, Amadesi, Stefano, Palombo, Marta, Lazzarotto, Tiziana, Ambretti, Simone, Gaibani, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10433922/
https://www.ncbi.nlm.nih.gov/pubmed/37600494
http://dx.doi.org/10.1093/jacamr/dlad099
_version_ 1785091759921954816
author Bovo, Federica
Amadesi, Stefano
Palombo, Marta
Lazzarotto, Tiziana
Ambretti, Simone
Gaibani, Paolo
author_facet Bovo, Federica
Amadesi, Stefano
Palombo, Marta
Lazzarotto, Tiziana
Ambretti, Simone
Gaibani, Paolo
author_sort Bovo, Federica
collection PubMed
description OBJECTIVES: Herein, we describe the epidemiology of carbapenemase-producing Enterobacterales (CPE) before and during the COVID-19 pandemic. Also, we report the emergence of an outbreak of Klebsiella pneumoniae strains co-producing KPC and OXA-181 carbapenemase, resistant to novel β-lactam/β-lactamase inhibitors (βL-βLICs) and cefiderocol. METHODS: CPE were collected during a period of 3 years from 2019 to 2021. Antimicrobial susceptibility testing for novel βL-βLICs and cefiderocol was performed by MIC test strips and microdilution with iron-depleted broth. WGS was performed on 10 selected isolates using the Illumina platform, and resistome analysis was carried out by a web-based pipeline. RESULTS: Between January 2019 and December 2021, we collected 1430 carbapenemase producers from 957 patients with infections due to CPE. KPC was the most common carbapenemase, followed by VIM, OXA-48 and NDM. During 2021, we identified 78 K. pneumoniae co-producing KPC and OXA-181 carbapenemases in 60 patients, resistant to meropenem/vaborbactam and imipenem/relebactam. Resistance to ceftazidime/avibactam and cefiderocol was observed respectively in 7 and 8 out of the 10 sequenced K. pneumoniae. Genome analysis showed that all isolates were clonally related, shared a common porin and plasmid content, and carried bla(OXA-181) and bla(KPC) carbapenemases. Specifically, 4 out of 10 isolates carried bla(KPC-3), while 6 harboured mutated bla(KPC). Of note, KPC producers resistant to ceftazidime/avibactam and harbouring mutated bla(KPC) exhibited higher MICs of cefiderocol (median MIC 16 mg/L, IQR 16–16) than strains harbouring WT bla(KPC-3) (cefiderocol 9 mg/L, IQR 1.5–16). CONCLUSIONS: Our results highlight the need for continuous monitoring of CPE to limit widespread MDR pathogens carrying multiple mechanisms conferring resistance to novel antimicrobial molecules.
format Online
Article
Text
id pubmed-10433922
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-104339222023-08-18 Clonal dissemination of Klebsiella pneumoniae resistant to cefiderocol, ceftazidime/avibactam, meropenem/vaborbactam and imipenem/relebactam co-producing KPC and OXA-181 carbapenemase Bovo, Federica Amadesi, Stefano Palombo, Marta Lazzarotto, Tiziana Ambretti, Simone Gaibani, Paolo JAC Antimicrob Resist Original Article OBJECTIVES: Herein, we describe the epidemiology of carbapenemase-producing Enterobacterales (CPE) before and during the COVID-19 pandemic. Also, we report the emergence of an outbreak of Klebsiella pneumoniae strains co-producing KPC and OXA-181 carbapenemase, resistant to novel β-lactam/β-lactamase inhibitors (βL-βLICs) and cefiderocol. METHODS: CPE were collected during a period of 3 years from 2019 to 2021. Antimicrobial susceptibility testing for novel βL-βLICs and cefiderocol was performed by MIC test strips and microdilution with iron-depleted broth. WGS was performed on 10 selected isolates using the Illumina platform, and resistome analysis was carried out by a web-based pipeline. RESULTS: Between January 2019 and December 2021, we collected 1430 carbapenemase producers from 957 patients with infections due to CPE. KPC was the most common carbapenemase, followed by VIM, OXA-48 and NDM. During 2021, we identified 78 K. pneumoniae co-producing KPC and OXA-181 carbapenemases in 60 patients, resistant to meropenem/vaborbactam and imipenem/relebactam. Resistance to ceftazidime/avibactam and cefiderocol was observed respectively in 7 and 8 out of the 10 sequenced K. pneumoniae. Genome analysis showed that all isolates were clonally related, shared a common porin and plasmid content, and carried bla(OXA-181) and bla(KPC) carbapenemases. Specifically, 4 out of 10 isolates carried bla(KPC-3), while 6 harboured mutated bla(KPC). Of note, KPC producers resistant to ceftazidime/avibactam and harbouring mutated bla(KPC) exhibited higher MICs of cefiderocol (median MIC 16 mg/L, IQR 16–16) than strains harbouring WT bla(KPC-3) (cefiderocol 9 mg/L, IQR 1.5–16). CONCLUSIONS: Our results highlight the need for continuous monitoring of CPE to limit widespread MDR pathogens carrying multiple mechanisms conferring resistance to novel antimicrobial molecules. Oxford University Press 2023-08-17 /pmc/articles/PMC10433922/ /pubmed/37600494 http://dx.doi.org/10.1093/jacamr/dlad099 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of British Society for Antimicrobial Chemotherapy. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Bovo, Federica
Amadesi, Stefano
Palombo, Marta
Lazzarotto, Tiziana
Ambretti, Simone
Gaibani, Paolo
Clonal dissemination of Klebsiella pneumoniae resistant to cefiderocol, ceftazidime/avibactam, meropenem/vaborbactam and imipenem/relebactam co-producing KPC and OXA-181 carbapenemase
title Clonal dissemination of Klebsiella pneumoniae resistant to cefiderocol, ceftazidime/avibactam, meropenem/vaborbactam and imipenem/relebactam co-producing KPC and OXA-181 carbapenemase
title_full Clonal dissemination of Klebsiella pneumoniae resistant to cefiderocol, ceftazidime/avibactam, meropenem/vaborbactam and imipenem/relebactam co-producing KPC and OXA-181 carbapenemase
title_fullStr Clonal dissemination of Klebsiella pneumoniae resistant to cefiderocol, ceftazidime/avibactam, meropenem/vaborbactam and imipenem/relebactam co-producing KPC and OXA-181 carbapenemase
title_full_unstemmed Clonal dissemination of Klebsiella pneumoniae resistant to cefiderocol, ceftazidime/avibactam, meropenem/vaborbactam and imipenem/relebactam co-producing KPC and OXA-181 carbapenemase
title_short Clonal dissemination of Klebsiella pneumoniae resistant to cefiderocol, ceftazidime/avibactam, meropenem/vaborbactam and imipenem/relebactam co-producing KPC and OXA-181 carbapenemase
title_sort clonal dissemination of klebsiella pneumoniae resistant to cefiderocol, ceftazidime/avibactam, meropenem/vaborbactam and imipenem/relebactam co-producing kpc and oxa-181 carbapenemase
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10433922/
https://www.ncbi.nlm.nih.gov/pubmed/37600494
http://dx.doi.org/10.1093/jacamr/dlad099
work_keys_str_mv AT bovofederica clonaldisseminationofklebsiellapneumoniaeresistanttocefiderocolceftazidimeavibactammeropenemvaborbactamandimipenemrelebactamcoproducingkpcandoxa181carbapenemase
AT amadesistefano clonaldisseminationofklebsiellapneumoniaeresistanttocefiderocolceftazidimeavibactammeropenemvaborbactamandimipenemrelebactamcoproducingkpcandoxa181carbapenemase
AT palombomarta clonaldisseminationofklebsiellapneumoniaeresistanttocefiderocolceftazidimeavibactammeropenemvaborbactamandimipenemrelebactamcoproducingkpcandoxa181carbapenemase
AT lazzarottotiziana clonaldisseminationofklebsiellapneumoniaeresistanttocefiderocolceftazidimeavibactammeropenemvaborbactamandimipenemrelebactamcoproducingkpcandoxa181carbapenemase
AT ambrettisimone clonaldisseminationofklebsiellapneumoniaeresistanttocefiderocolceftazidimeavibactammeropenemvaborbactamandimipenemrelebactamcoproducingkpcandoxa181carbapenemase
AT gaibanipaolo clonaldisseminationofklebsiellapneumoniaeresistanttocefiderocolceftazidimeavibactammeropenemvaborbactamandimipenemrelebactamcoproducingkpcandoxa181carbapenemase